Clinical evaluation of the efficacy of Shur breath (Sylphar) in the reduction of bad breath

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010618

Enrollment

Registered

2016-06-10

Start date

2016-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R19.6

Interventions

Group 1: Shur Breath 2x daily (1st after brushing and 2 after 6 h) 14 days Group 2: Fresh Breath Halitosis meridol mouthrinse 2x daily 15 ml after brushing 14 days Group 3: Tap water 15 ml 2x daily af

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 , Halimeter ( InterScan ) measurement > 150ppb, Good knowledge of the German language to understand the subjects information education, Signed consent subjects

Exclusion criteria

Exclusion criteria: alcoholism, nicotine, pregnancy or lactation, participation in a clinical trial within the last 30 days, active caries, acute sinusitis, strong oropharyngeal infection, medicines can cause halitosis, reduced salivation, subjects eat the food very sharp, volunteers receiving homeopathic treatment, Taking antibiotics 2 months prior to study entry, eat frequent gum, subjects who do not comply with the study protocol, severe systemic disease, Known hypersensitivity to a substance used in the study, serious oral diseases , such as acute ulcerative gingivitis acute gingivostomatitis, orthodontic appliances

Design outcomes

Primary

Measure	Time frame
The primary endpoint is before the reduction of volatile sulfur compounds with the Halimeter® ( InterScan ) and proof of anti - adhesion anaerobic bacteria and after one or two weeks of use of the new product . The differences tested ( before - after ) are using the variance analysis on significant group differences ( significance level 0.05 ) . Then alpha -adjusted , post-hoc tests are performed ( Holm - Bonferroni ) . Depending on the distribution of data , statistical tests are applied ( SPSS version 22 )	—

Measure

Time frame

The primary endpoint is before the reduction of volatile sulfur compounds with the Halimeter® ( InterScan ) and proof of anti - adhesion anaerobic bacteria and after one or two weeks of use of the new product . The differences tested ( before - after ) are using the variance analysis on significant group differences ( significance level 0.05 ) . Then alpha -adjusted , post-hoc tests are performed ( Holm - Bonferroni ) . Depending on the distribution of data , statistical tests are applied ( SPSS version 22 )

—

Countries

Germany

Contacts

Public ContactStephan Sauer

Universität Witten/ HerdeckeFakultät für Gesundheit (Department für Zahn-, Mund- und Kieferheilkunde)Lehrstuhl für Zahnerhaltung und Präventive Zahnmedizin

stephan.sauer@uni-wh.de02302 926653

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026